![Insurance Foresight](https://www.nortonrosefulbright.com/-/media/images/nrf/hero/nrf-insurance-foresight---06.jpg?w=265&revision=2197b77d-e355-4a68-9e24-a72e5d9c2d40&revision=5250127931077387904&hash=C89E7CE2D226E64D1975BA2EE0E09A19)
Publication
Insurance M&A: On the cusp of a new era?
Early indications are that 2025 will see the start of a new phase in the cycle and it could be a busy year for M&A across the insurance sector.
Authors:
United States | Publication | November 2023
Healthcare in America is big business. With annual expenditures in 2021 topping US$4.5 trillion, healthcare spending consumes 18.3 percent of the US gross domestic product. More than half of personal healthcare expenditures in the US are subsidized financially by the public sector, which makes government a key policy actor.
Susan Feigin Harris, Elise LeGros, Kathleen Rubinstein (Houston), Jeff Wurzburg (San Antonio/Washington, DC) and David Aplington (St. Louis), with Stacey Murphy (St. Louis), Mark Faccenda (Washington, DC), Denise Webb Glass, Jennifer Ann McDaniel (Dallas), Susan Linda Ross and Gerald A. Stein (New York) address a multitude of laws and regulations governing the US healthcare industry in their Lexology article, "Getting the Deal Through: Healthcare Regulation 2024."
Publication
Early indications are that 2025 will see the start of a new phase in the cycle and it could be a busy year for M&A across the insurance sector.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025